BlackRock’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78.8M | Sell |
|
|||||
|
2025
Q2 | $106M | Buy |
|
|||||
|
2025
Q1 | $87.4M | Sell |
|
|||||
|
2024
Q4 | $105M | Buy |
|
|||||
|
2024
Q3 | $249M | Buy |
|
|||||
|
2024
Q2 | $166M | Buy |
|
|||||
|
2024
Q1 | $272M | Sell |
|
|||||
|
2023
Q4 | $278M | Buy |
|
|||||
|
2023
Q3 | $213M | Buy |
|
|||||
|
2023
Q2 | $230M | Buy |
|
|||||
|
2023
Q1 | $225M | Sell |
|
|||||
|
2022
Q4 | $216M | Buy |
|
|||||
|
2022
Q3 | $268M | Buy |
|
|||||
|
2022
Q2 | $195M | Buy |
|
|||||
|
2022
Q1 | $200M | Buy |
|
|||||
|
2021
Q4 | $163M | Buy |
|
|||||
|
2021
Q3 | $174M | Sell |
|
|||||
|
2021
Q2 | $122M | Sell |
|
|||||
|
2021
Q1 | $119M | Buy |
|
|||||
|
2020
Q4 | $89.8M | Buy |
|
|||||
|
2020
Q3 | $65.5M | Sell |
|
|||||
|
2020
Q2 | $41.5M | Buy |
|
|||||
|
2020
Q1 | $30.9M | Sell |
|
|||||
|
2019
Q4 | $57.6M | Sell |
|
|||||
|
2019
Q3 | $46.6M | Buy |
|
|||||
|
2019
Q2 | $40.3M | Buy |
|
|||||
|
2019
Q1 | $60.3M | Buy |
|
|||||
|
2018
Q4 | $93.1M | Buy |
|
|||||
|
2018
Q3 | $130M | Buy |
|
|||||
|
2018
Q2 | $91.8M | Buy |
|
|||||
|
2018
Q1 | $53.5M | Sell |
|
|||||
|
2017
Q4 | $46.3M | Buy |
|
|||||
|
2017
Q3 | $60.7M | Buy |
|
|||||
|
2017
Q2 | $61.2M | Buy |
|
|||||
|
2017
Q1 | $23.7M | Buy |
|
|||||
|
2016
Q4 | $70K | Buy |
|
|||||
|
2016
Q3 | $111K | Buy |
|
|||||
|
2016
Q2 | $70K | Buy |
|
|||||
|
2016
Q1 | $15K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $123K | Buy |
|